Activation of the <i>glmS</i> Ribozyme Confers Bacterial Growth Inhibition

Anna Schüller, Daniel Matzner, Christina E. Weinberg, Valentin Wittmann, Catherine Schumacher, Sandra Unsleber, Heike Brötz‐Oesterhelt, Christoph Mayer, Gabriele Bierbaum, Günter Mayer

ChemBioChem · 2016 · 28 citations · 26 references

Concepts

Abstract

The ever-growing number of pathogenic bacteria resistant to treatment with antibiotics call for the development of novel compounds with as-yet unexplored modes of action. Here, we demonstrate the in vivo antibacterial activity of carba-α-d-glucosamine (CGlcN). In this mode of action study, we provide evidence that CGlcN-mediated growth inhibition is due to glmS ribozyme activation, and we demonstrate that CGlcN hijacks an endogenous activation pathway, hence utilizing a prodrug mechanism. This is the first report describing antibacterial activity mediated by activating the self-cleaving properties of a ribozyme. Our results open the path towards a compound class with an entirely novel and distinct molecular mechanism.

References

26